Finance Home
-
My Yahoo
-
Yahoo!
-
Help
Sunday, December 27, 2009, 1:06PM ET - U.S. Markets Closed.
Dow
0.51%
Nasdaq
0.71%
Home
Investing
Market Overview
Market Stats
Stocks
Mutual Funds
ETFs
Bonds
Options
Industries
Currencies
New!
Education
News & Opinion
Markets
Investing Ideas
Expert Advice
Special Editions
Company Finances
Providers
Personal Finance
Banking & Budgeting
Career & Work
College & Education
Family & Home
Insurance
Loans
Real Estate
Retirement
Taxes
How-to Guides
My Portfolios
Sign In to Create/Edit My Portfolios
Free trial of Real-Time Quotes
Tech Ticker
Get Quotes
Finance Search
Transition Therapeutics Inc. (TTHI)
On
Dec 24
:
3.55
0.02
(0.56%)
MORE ON TTHI
Quotes
Summary
Real-Time
Options
Historical Prices
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Financial Blogs
Company Events
Message Board
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Research Reports
Get
Research Reports
for:
RECENT REPORTS
Released
Contributor
Author
Title
Pages
Price
26-Dec-2009
Standard & Poor's Quantitative Report
N/A
Transition Therapeutics
6
$25
25-Dec-2009
Pechala's Reports
Frantisek Pechala
TRANSITION THERAPEUTICS INC CANADA (TTHI=US) 12-months forecast
1
$15
24-Dec-2009
Pechala's Reports
Lubomir Pechala
TRANSITION THERAPEUTICS INC CANADA (TTHI=US) 2-weeks forecast
1
$10
23-Dec-2009
ValuEngine, Inc.
N/A
ValuEngine Industry Report for HOME HEALTH CARE
18
$49
21-Dec-2009
TheStreet.com Ratings
N/A
TheStreet.com Ratings Stock Report For: TRANSITION THERAPEUTICS INC
5
$25
21-Dec-2009
ValuEngine, Inc.
N/A
ValuEngine Detailed Valuation Report for TTHI
13
$25
16-Dec-2009
Roth Capital Partners, Inc.
Research Department
Morning Call Summary
10
$25
15-Dec-2009
Zacks Investment Research Inc.
N/A
TRANSITN THERAP (TTHI) Zacks Company Snapshot
1
$10
15-Dec-2009
Roth Capital Partners, Inc.
Scott R. Henry CFA, Andrew Vaino PhD
Highest Doses ELND005 Pulled, Downgrading To HOLD
5
$10
8-Dec-2009
RiskMetrics Group
N/A
ISS Report on Transition Therapeutics Inc.
5
$100
View All Reports for TTHI ...
Add to Portfolio
Set Alert
Email to a Friend
Get
Research Reports
for Another Symbol:
Symbol Lookup
Upgrades & Downgrades
Conference Calls